FDA's Departure Dilemma: What This Means for Public Trust in Regulation The latest high level departure from the Food and Drug Administration (FDA) has left many wondering about the future of regulatory oversight. Dr.
Tracy Beth Høeg, a polarizing figure within the agency, is leaving her post as acting director of the Center for Drug Evaluation and Research (CDER).
This news follows closely on the heels of former FDA Commissioner Dr. Marty Makary's resignation, which was reportedly linked to internal tensions over the approval of flavored e cigarettes.